Susquehanna Fundamental Investments’s Gossamer Bio GOSS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$149K	Sell	214 -586	-73%	-$452K	﹤0.01%	1412
2021 Q4	$724K	Sell	800 -54	-6%	-$51.3K	0.02%	776
2021 Q3	$859K	Buy	+854	New	+$629K	0.02%	932
2020 Q4	–	Sell	-745	Closed	-$740K	–	1538
2020 Q3	$740K	Buy	745 +230	+45%	+$244K	0.02%	744
2020 Q2	$536K	Buy	+515	New	+$518K	0.03%	601

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna Fundamental Investments's GOSS Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Gossamer Bio (GOSS) stake by 73% in Q1 2022, selling an estimated $452K and leaving 214 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Susquehanna Fundamental Investments first reported a position in GOSS in Q2 2020 and has held it in 5 quarters since. The position peaked at $859K in Q3 2021. 139 funds tracked by Wall St. Rank hold GOSS as of Q1 2022.

Susquehanna Fundamental Investments held 214 shares of Gossamer Bio worth $149K as of Q1 2022.
Susquehanna Fundamental Investments sold 586 Gossamer Bio shares in Q1 2022, an estimated $452K.
Gossamer Bio made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1412 holding.
Susquehanna Fundamental Investments first reported a position in Gossamer Bio in Q2 2020 and has held it in 5 quarters since.
Susquehanna Fundamental Investments's Gossamer Bio position peaked at $859K in Q3 2021.
139 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.